MDClone Company Profile

Background

Founded in 2016 and headquartered in Be'er Sheva, Israel, MDClone is a pioneering healthcare data exploration platform dedicated to transforming the global healthcare landscape. The company's mission is to empower healthcare organizations to harness the full potential of their data, driving impactful changes that enhance patient health and clinical outcomes. MDClone's vision centers on facilitating rapid, data-driven innovation by enabling front-line staff to independently explore and analyze their organization's data, thereby fostering a culture of continuous improvement and collaboration within the healthcare industry.

Key Strategic Focus

MDClone's strategic focus is on democratizing access to healthcare data through its innovative platforms, particularly the MDClone ADAMS Platform. This self-service data analytics environment allows users to organize, access, and protect patient data privacy, enabling rapid transformation of ideas into actionable insights. The platform's core objectives include:

Empowering Healthcare Professionals: Providing tools that allow clinicians, researchers, and administrators to independently explore data, leading to faster and more informed decision-making.

Enhancing Data Privacy: Utilizing synthetic data generation to ensure patient confidentiality while maintaining the utility of the data for analysis.

Facilitating Collaboration: Enabling secure data sharing within and between organizations to drive collective innovation and improve patient outcomes.

MDClone primarily targets healthcare systems, government entities, payers, and life sciences companies across the United States, Canada, Europe, and Israel, aiming to address the challenges of data accessibility and privacy in these markets.

Financials and Funding

MDClone has demonstrated robust financial growth, securing a total of $104 million in funding to date. The company's funding history includes:

Series C Funding (March 2022): Raised $63 million to support global expansion and platform enhancement. This round was led by Warburg Pincus and Viola Growth, with participation from aMoon, LightSpeed Venture Partners, and OrbiMed.

The capital raised is intended to fuel MDClone's expansion into new regional markets, with a particular focus on the Asia Pacific region, Europe, and the Middle East. Additionally, the funds will be used to enhance the existing platform and enter new vertical markets, including real-world evidence applications.

Technological Platform and Innovation

MDClone's technological innovation is epitomized by its ADAMS Platform, which offers a unique approach to healthcare data analytics:

Synthetic Data Engine: At the heart of the platform is the Synthetic Data Engine, which creates artificial datasets that replicate the statistical characteristics of real-world data without compromising patient privacy. This allows for extensive data analysis and sharing without the risks associated with handling actual patient information.

Self-Service Data Exploration: The platform enables users to engage in independent, self-service data investigation, allowing for rapid cycles of discovery and insight generation. This empowers healthcare professionals to swiftly transform ideas into actionable insights, driving positive changes in patient care.

Integration of Unstructured Data: MDClone's platform can integrate various data sources, including unstructured data, and employs natural language processing (NLP) to extract meaningful information, enhancing the depth and breadth of data analysis capabilities.

Leadership Team

MDClone's leadership team comprises seasoned professionals with extensive experience in healthcare technology and innovation:

Ziv Ofek, Co-Founder & CEO: A serial entrepreneur and leader in the e-Health sector, Ziv previously founded and served as Chief Innovation Officer of dbMotion, which was acquired by Allscripts for $235 million. He has over two decades of experience in medical informatics, with his inventions utilized in numerous hospitals and clinics worldwide.

Luz Erez, Co-Founder & Chief Innovation Officer: An engineer and scientist with expertise in complex data initiatives, Luz has held positions such as CTO and VP of Development in various firms. He specializes in big data projects and unique software and hardware technologies.

Peter Schon, Chief Operating Officer & Chief Financial Officer: With over 25 years of financial leadership experience, Peter has a proven track record in driving financial growth and strategic initiatives for global organizations. Prior to MDClone, he held senior finance positions in companies like Pixellot and Elcon Recycling.

Bruno Lempernesse, President: Bringing over 25 years of industry expertise, Bruno has a global footprint encompassing Europe and the USA. He has been a pioneer in Real-World Evidence and healthcare big data, focusing on the development and utilization of longitudinal patient data from electronic medical records.

Davidi Bachrach, Senior VP of International: Davidi leads MDClone's international business, including sales, business development, customer success, and support for international markets. He has extensive experience in digital health, data aggregation, and analysis.

Almog Ohayon, SVP Solution: Almog serves as the VP of R&D at MDClone, bringing vast experience in the software industry and healthcare field. He has a unique blend of technical expertise and strategic vision.

Michal Limor, VP of Human Resources: Michal has over 15 years of HR experience, shaping transformative landscapes across diverse industries and fostering high-performing teams.

Brandi Meyers, VP of Revenue Operations: Coordinating operations across sales, customer experience, and market strategies, Brandi brings over 20 years of healthcare IT leadership experience.

Dana Arditi, VP Customer Success International: Dana has over 20 years of leadership in Data and AI, with deep expertise in customer success, product management, and data analytics.

Peter Calderone, VP Customer Success North America: An accomplished healthcare technology executive with over 20 years of experience, Peter oversees a diverse team advancing initiatives in synthetic data, research, and quality improvement.

Daniel Blumenthal, VP of Strategy: Daniel leads efforts to expand key partnerships and develop new software, services, and collaborations globally. He has extensive experience building startup ecosystems and supporting entrepreneurs in the U.S. and Israel.

Competitor Profile

Market Insights and Dynamics

The healthcare data analytics market is experiencing significant growth, driven by the increasing need for data-driven decision-making, advancements in big data technologies, and the emphasis on improving patient outcomes. The market is characterized by rapid technological advancements and a growing emphasis on data privacy and security.

Competitor Analysis

MDClone operates in a competitive landscape with several key players:

Aetion: Specializes in real-world evidence and analytics, providing insights for drug companies, payers, and other healthcare stakeholders. Aetion's acquisition of Replica Analytics in January 2022 bolstered its capabilities in synthetic health data.

Replica Analytics: Focuses on AI-powered synthetic health data, enabling data sharing and analysis while preserving patient privacy. The company's acquisition by Aetion highlights the growing importance of synthetic data in healthcare analytics.

Other Competitors: The market also includes other data analytics firms and technology companies offering solutions for healthcare data analysis, each with varying focuses on data privacy, integration capabilities, and user accessibility.

Strategic Collaborations and Partnerships

MDClone has established significant collaborations to enhance its market position and innovation capacity:

Intermountain Healthcare: Partnered to load Intermountain's data into MDClone's Sandbox, enabling caregivers to better understand and manage patients by evaluating critical decision points in care journeys.

Regenstrief Institute: Collaborated to accelerate data-driven medical research by providing rapid and secure access to data, ensuring patient privacy through synthetic data generation.

The Global Network: Formed a research and knowledge-sharing collaborative with leading healthcare organizations from the U.S., Canada, and Israel, leveraging MDClone's platform to democratize data and improve patient health.

Operational Insights

MDClone's strategic considerations in relation to major competitors and market position include:

Data Privacy and Security: The company's synthetic data engine addresses critical concerns about patient privacy, providing a competitive edge in data sharing and collaboration.

User Empowerment: By offering a self-service platform, MDClone enables healthcare professionals to independently explore data, reducing reliance on IT departments and accelerating the pace of innovation.

Global Expansion: With significant funding and strategic partnerships, MDClone is well-positioned to expand into new markets, particularly in the Asia Pacific region, Europe, and the Middle East.

Strategic Opportunities and Future Directions

MDClone's strategic roadmap includes:

Platform Enhancement: Continuously developing new capabilities within the ADAMS Platform to meet evolving healthcare data needs.

Market Expansion: Entering new regional markets and verticals, including real-world evidence applications, to broaden the company's impact.

Collaborative Innovation: Strengthening existing partnerships and forming new alliances to drive collective innovation and improve patient outcomes globally.